Bioconjugates with Arginine Spacers for Collagen Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bioconjugates fail to effectively address the degradation of extracellular matrix in tissues, leading to conditions such as arthritis and tissue injuries, due to inadequate collagen binding affinity and stability.
Innovation Solution
Development of bioconjugates comprising a glycan and branched or unbranched peptides with a collagen-binding unit covalently bonded via a spacer, specifically utilizing a formula (I) where the spacer includes arginines to enhance collagen binding activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional bioconjugates are used, then the extracellular matrix degradation is not effectively addressed, but the collagen binding affinity and stability are inadequate
Solution Approach 1:
The patent modifies the chemical structure of bioconjugates by changing parameters such as incorporating specific amino acid sequences (collagen-binding units), adjusting spacer lengths (5-20 amino acids), and optimizing the linkage between glycan and peptides. These parameter changes result in enhanced collagen binding affinity and stability, directly addressing the inadequate binding performance of conventional bioconjugates.
Solution Approach 2:
The patent creates composite bioconjugate structures combining multiple functional components: glycans, peptides with collagen-binding units, spacers, and linkages. This composite approach integrates the benefits of each component to achieve both high collagen binding affinity and stability, while the branched peptide configuration provides improved binding through multiple interaction points.
2Reliability
If branched peptides are used, then collagen binding activity is enhanced, but the structural complexity increases
Solution Approach 1:
The patent segments the peptide structure into distinct functional modules: collagen-binding units, spacers, and linkage regions. This segmentation allows the complex branched peptide structure to be designed and assembled from standardized components, improving collagen binding activity through modular configuration while managing structural complexity through systematic design.
Solution Approach 2:
The patent transitions from linear peptide structures to branched three-dimensional configurations. This dimensional change enables multiple collagen-binding units to be positioned in spatial arrangement that enhances binding activity through increased interaction surface area and multiple binding sites, while the spacer regions maintain structural manageability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The bioconjugates exhibit improved collagen binding affinity, reducing tissue degradation and promoting tissue repair by effectively interacting with collagen in the extracellular matrix.
Implementation Method 1
at least one binding unit of formula (I) covalently bonded thereto
Implementation Method 2
L comprises at least two arginines (R) within the first five amino acids from the glycan... leads to increased binding of certain peptides to their targets
Data Source
AI summary
Provided herein are bioconjugates comprising a backbone and at least one branched or unbranched peptide having at least one collagen-binding unit covalently bonded thereto via a spacer and methods of use thereof.